CorMedix Revenue and Competitors

Bedminster, NJ USA

Location

$11.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • CorMedix's estimated annual revenue is currently $7.5M per year.(i)
  • CorMedix's estimated revenue per employee is $87,209
  • CorMedix's total funding is $11.5M.

Employee Data

  • CorMedix has 86 Employees.(i)
  • CorMedix grew their employee count by -5% last year.

CorMedix's People

NameTitleEmail/Phone
1
Chief Clinical Strategy & Operations OfficerReveal Email/Phone
2
EVP, Head Clinical and Medical AffairsReveal Email/Phone
3
SVP and Head Global QualityReveal Email/Phone
4
SVP, Head Global QualityReveal Email/Phone
5
Head Patient Advocacy and Special ProjectsReveal Email/Phone
6
EVP and General CounselReveal Email/Phone
7
Senior Key Account DirectorReveal Email/Phone
8
Director, Quality SystemsReveal Email/Phone
9
Executive Director Clinical DevelopmentReveal Email/Phone
10
EVP and Chief Commercial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is CorMedix?

Scientific evidence indicates that cardiovascular and kidney disease are inextricably intertwined.CorMedix has two foundational technologies. The first prevents and/or treats cardiorenal diseases by reducing tissue-damaging oxidative stress caused by excess ("labile" or "toxic") iron.

keywords:Biotechnology, Healthcare

$11.5M

Total Funding

86

Number of Employees

$7.5M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CorMedix News

2022-04-06 - CorMedix Inc. Announces Scientific Advisory Board to Support ...

CorMedix is focused on preparing for a potential commercial launch in hemodialysis and aims to explore the safety and effectiveness of DefenCath...

2022-03-30 - CorMedix Inc. Reports Fourth Quarter and Full Year 2021 ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of...

2022-03-22 - CorMedix Inc. Announces FDA Acceptance of Resubmission ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.2M10120%N/A
#2
$25.6M1226%N/A
#3
$29.7M13512%N/A
#4
$32.3M1401%N/A
#5
$44.3M15022%N/A